Riverbank Capital Securities is a New York-based venture capital firm specialized in early and late stage venture investments.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 9, 2011
Kite Pharma
|
Series A | $15M | Biotechnology | — |
Sep 28, 2010
Tigris Pharmaceuticals
|
Series C | $6.50M | Biotechnology | — |
Jan 17, 2007
Tigris Pharmaceuticals
|
Series B | $16M | Biotechnology | — |
Riverbank Capital Securities has had 1 exits. Riverbank Capital Securities most notable exits include Kite Pharma
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jun 27, 2014 | Kite Pharma | M&A | Biotechnology | Detail |